Greatbatch (GB) Drops 12.63% on January 12

Equities Staff |

Greatbatch (GB) was one of the Russell 2000's biggest losers for Tuesday January 12 as the stock slid 12.63% to $43.58, a loss of $-6.3 per share. Starting at an opening price of $46.45 a share, the stock traded between $43.05 and $49.45 over the course of the trading day. Volume was 485,982 shares over 4,380 trades, against an average daily volume of 222,897 shares and a total float of 30.56 million.

The losses send Greatbatch down to a market cap of $1.33 billion. In the last year, Greatbatch has traded between $63.19 and $47.36, and its 50-day SMA is currently $55.36 and 200-day SMA is $54.33.

The stock has a P/E Ratio of 41.5.

Greatbatch Inc designs and manufactures critical components that help to advance medical device technology across various applications. The Company operates in two segments namely Greatbatch Medical and QiG Group.

Greatbatch is based out of Frisco, TX and has some 3,690 employees. Its CEO is Thomas J. Hook.

For a complete fundamental analysis analysis of Greatbatch, check out’s Stock Valuation Analysis report for GB. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Pressure Biosciences Inc

Pressure BioSciences Inc is a biological life sciences research company. It is engaged in the development and commercialization of a platform technology called pressure cycling technology.

Private Markets

Santo Diablo Mezcal

Santo Diablo Mezcal has been created to capitalize on a boom sector of the beverage market currently full of many small unmemorable products by producing one sexy, household, easily recognizable…


Blockchain currencies (e.g. Bitcoin) provide a new disruptive way to transfer value between parties over the internet as opposed to going through banks. GoCoin provides online merchants with a suite…